News

Aug. 30 is the deadline for skilled nursing facilities to preview their quality measure data for the Nursing Home Compare website refresh in October and ask the Centers for Medicare & Medicaid Services to review their data if they believe the scores are inaccurate.

SCA Pharmaceuticals has recalled 10 lots of compounded heparin sodium, an anticoagulant packaged in 500 mL or 1000 mL intravenous bags, the Food and Drug Administration announced.

The Centers for Medicare & Medicaid Services yesterday published guidance for states on the treatment of third party payers in determining the hospital-specific Medicaid disproportionate share hospital payment limits for the state plan rate year 2017 DSH audits.

The AHA urged the Office of Management and Budget to expedite its review and release of final regulations on physician self-referral and the Anti-Kickback Statute that were submitted in July by the Centers for Medicare & Medicaid Services and the Department of Health & Human Services Office of Inspector General.

The Centers for Disease Control and Prevention released a study examining how COVID-19 is affecting American Indians and Alaska Natives — one of the populations at highest risk for the disease.

The Department of Health and Human Services amended the declaration under the Public Readiness and Emergency Preparedness Act to authorize state-licensed pharmacists and pharmacy interns under their supervision to order and administer vaccines to children, subject to certain requirements.

The Food and Drug Administration released a resource to help U.S. health care providers select respirators for their health care facility.

The National Institute for Occupational Safety and Health released a report summarizing the particulate filtration efficiency of non-NIOSH-approved N95 respirators made in other countries and authorized for emergency use during the COVID-19 public health emergency.

The AHA urged President Trump and the Department of Health and Human Services to continue to act on behalf of hospitals and health systems by further expanding telehealth flexibilities.

The AHA unveiled the latest component of the association’s Wear A Mask initiative, with new content and collaborations to share resources and amplify key public health messages to stop the spread of COVID-19.

At Dell Seton Medical Center, clinicians observed that patients with opioid use disorder had a high likelihood of readmission because its underlying causes were not being addressed.

A federal district court in New York blocked the Department of Health and Human Services from revising a 2016 rule implementing nondiscrimination protections for patients under Section 1557 of the Affordable Care Act.

Michelle Hood, AHA’s executive vice president and chief operating officer, previews the association’s Sept. 14-16 virtual conference, Navigating a New Reality: Health Care Leaders Confront the Future, sponsored by the AHA Center for Health Innovation and the Society for Health Care Strategy and Market Development to help health care leaders successfully move forward through COVID-19’s recovery, rebuilding and reimagining care delivery.

One in four U.S. counties, or 818,  were COVID-19 hotspots for at least one day in the period between March 8 and July 15, representing 80% of the U.S. population, according to a report released by the Centers for Disease Control and Prevention.

A test kit made by Thermo Fisher Scientific to detect COVID-19 from respiratory specimens may produce false positive results, the Food and Drug Administration warned.

The Centers for Disease Control and Prevention updated its guidance for determining when health care personnel with confirmed or suspected COVID-19 may return to work.

The Centers for Medicare & Medicaid Services announced it will resume routine inspections of all Medicare- and Medicaid-certified providers and suppliers that were previously suspended as part of its response to the COVID-19 pandemic.

The Centers for Medicare & Medicaid Services updated its guidance related to the 20% inpatient prospective payment system diagnosis-related group rate add-on for patients diagnosed with COVID-19.

HHS delayed today’s expected release of additional details regarding data elements for providers who accepted Provider Relief Fund program funds.

FDA Saturday issued an emergency use authorization to Yale School of Public Health for a new test to detect SARS-CoV-2 in saliva.